Bank of Montreal’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-21,309
| Closed | -$600K | – | 3518 |
|
|
2024
Q3 | $600K | Sell |
21,309
-132
| -0.6% | -$3.25K | ﹤0.01% | 2293 |
|
|
2024
Q2 | $488K | Buy |
21,441
+831
| +4% | +$19.2K | ﹤0.01% | 2419 |
|
|
2024
Q1 | $628K | Hold |
20,610
| – | – | ﹤0.01% | 2283 |
|
|
2023
Q4 | $771K | Sell |
20,610
-89
| -0.4% | -$3.31K | ﹤0.01% | 2223 |
|
|
2023
Q3 | $994K | Sell |
20,699
-88
| -0.4% | -$4.29K | ﹤0.01% | 2066 |
|
|
2023
Q2 | $1.04M | Sell |
20,787
-1,848
| -8% | -$85.2K | ﹤0.01% | 2165 |
|
|
2023
Q1 | $953K | Buy |
22,635
+1,897
| +9% | +$78.7K | ﹤0.01% | 2073 |
|
|
2022
Q4 | $923K | Sell |
20,738
-3,943
| -16% | -$165K | ﹤0.01% | 2230 |
|
|
2022
Q3 | $1.07K | Buy |
24,681
+19,777
| +403% | +$905K | ﹤0.01% | 2134 |
|
|
2022
Q2 | $201 | Buy |
4,904
+126
| +3% | +$5.97K | ﹤0.01% | 3271 |
|
|
2022
Q1 | $311K | Sell |
4,778
-560
| -10% | -$36.3K | ﹤0.01% | 3163 |
|
|
2021
Q4 | $373K | Buy |
5,338
+623
| +13% | +$45.3K | ﹤0.01% | 2602 |
|
|
2021
Q3 | $330K | Buy |
4,715
+104
| +2% | +$8K | ﹤0.01% | 3081 |
|
|
2021
Q2 | $370K | Sell |
4,611
-2,231
| -33% | -$162K | ﹤0.01% | 2984 |
|
|
2021
Q1 | $455K | Sell |
6,842
-63,163
| -90% | -$3.89M | ﹤0.01% | 2700 |
|
|
2020
Q4 | $4.17M | Sell |
70,005
-11,042
| -14% | -$477K | ﹤0.01% | 1492 |
|
|
2020
Q3 | $3.21M | Buy |
81,047
+698
| +0.9% | +$29.6K | ﹤0.01% | 1445 |
|
|
2020
Q2 | $3.54M | Buy |
80,349
+5,990
| +8% | +$261K | ﹤0.01% | 1342 |
|
|
2020
Q1 | $2.45M | Sell |
74,359
-22,333
| -23% | -$803K | ﹤0.01% | 1334 |
|
|
2019
Q4 | $3.14M | Buy |
96,692
+52,888
| +121% | +$1.51M | ﹤0.01% | 1627 |
|
|
2019
Q3 | $1.09M | Sell |
43,804
-1,573
| -3% | -$44.9K | ﹤0.01% | 2027 |
|
|
2019
Q2 | $1.35M | Sell |
45,377
-528
| -1% | -$15.4K | ﹤0.01% | 1924 |
|
|
2019
Q1 | $1.23M | Sell |
45,905
-3,008
| -6% | -$91.4K | ﹤0.01% | 1938 |
|
|
2018
Q4 | $1.5M | Buy |
48,913
+289
| +0.6% | +$9K | ﹤0.01% | 1676 |
|
|
2018
Q3 | $1.7M | Buy |
48,624
+9,481
| +24% | +$300K | ﹤0.01% | 1762 |
|
|
2018
Q2 | $1.06M | Sell |
39,143
-2,747
| -7% | -$64.6K | ﹤0.01% | 1975 |
|
|
2018
Q1 | $860K | Sell |
41,890
-1,847
| -4% | -$33.4K | ﹤0.01% | 1986 |
|
|
2017
Q4 | $798K | Buy |
43,737
+34,967
| +399% | +$692K | ﹤0.01% | 2059 |
|
|
2017
Q3 | $196K | Sell |
8,770
-1,692
| -16% | -$38.3K | ﹤0.01% | 2675 |
|
|
2017
Q2 | $253K | Hold |
10,462
| – | – | ﹤0.01% | 2548 |
|
|
2017
Q1 | $200K | Buy |
10,462
+128
| +1% | +$2.24K | ﹤0.01% | 2469 |
|
|
2016
Q4 | $186K | Buy |
10,334
+9,852
| +2,044% | +$179K | ﹤0.01% | 2523 |
|
|
2016
Q3 | $8K | Buy |
+482
| New | +$7.41K | ﹤0.01% | 3596 |
|
|
2015
Q2 | – | Sell |
-13,638
| Closed | -$279K | – | 3927 |
|
|
2015
Q1 | $279K | Sell |
13,638
-1,413
| -9% | -$27.4K | ﹤0.01% | 2225 |
|
|
2014
Q4 | $300K | Hold |
15,051
| – | – | ﹤0.01% | 2299 |
|
|
2014
Q3 | $222K | Sell |
15,051
-600
| -4% | -$9.56K | ﹤0.01% | 2481 |
|
|
2014
Q2 | $288K | Sell |
15,651
-8,227
| -34% | -$137K | ﹤0.01% | 2362 |
|
|
2014
Q1 | $449K | Sell |
23,878
-7,604
| -24% | -$156K | ﹤0.01% | 2111 |
|
|
2013
Q4 | $588K | Buy |
31,482
+24,925
| +380% | +$362K | ﹤0.01% | 1728 |
|
|
2013
Q3 | $72K | Buy |
+6,557
| New | +$64.6K | ﹤0.01% | 2639 |
|
Other funds holding ATRC
HRCM
CIP
FLAM
N
Bank of Montreal's ATRC Position: Q4 2024 in Review
Bank of Montreal sold out of AtriCure (ATRC) in Q4 2024, closing a stake of 21,309 shares — an estimated $600K sold.
Bank of Montreal first reported a position in ATRC in Q3 2013 and held it in 40 quarters. The position peaked at $4.17M in Q4 2020. 213 funds tracked by Wall St. Rank hold ATRC as of Q4 2024.
- Bank of Montreal reported no remaining AtriCure position as of Q4 2024 after selling out during the quarter.
- Bank of Montreal sold 21,309 AtriCure shares in Q4 2024, an estimated $600K.
- Bank of Montreal first reported a position in AtriCure in Q3 2013 and held it in 40 quarters.
- Bank of Montreal's AtriCure position peaked at $4.17M in Q4 2020.
- 213 funds tracked by Wall St. Rank held AtriCure as of Q4 2024.
Based on Bank of Montreal's 13F filing for Q4 2024, filed 13 Feb 2025.